The Europe pharmaceutical glass packaging market is expected to grow significantly, increasing from about USD 5.79 billion in 2026 to nearly USD 12.39 billion by 2035, at a steady annual growth rate of around 8.8%. This growth is mainly driven by the rising use of biologic medicines and temperature-sensitive drugs that require reliable cold-chain storage. Across Europe, there is strong demand for high-quality borosilicate glass packaging because it helps prevent contamination, keeps medicines stable, and ensures they can be stored safely for long periods.